A phase IIa multicentre randomised double-blind, double-dummy study to evaluate the efficacy and safety of K-111 versus Fenofibrate in patients with hyperlipidaemia.

Next Previous
Trial Profile

A phase IIa multicentre randomised double-blind, double-dummy study to evaluate the efficacy and safety of K-111 versus Fenofibrate in patients with hyperlipidaemia.

Completed
Phase of Trial: Phase II

Latest Information Update: 23 Jul 2011

At a glance

  • Drugs Fenofibrate; K 111
  • Indications Hyperlipidaemia
  • Focus Adverse reactions; Therapeutic Use
  • Sponsors Kowa

    • Most Recent Events

    • 23 Jul 2011 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top